Search results
23 sie 2023 · The goal of treatment is to have no hepatitis C virus found in the body for at least 12 weeks after treatment ends. Some newer antiviral medicines, called direct-acting, have better outcomes, fewer side effects and shorter treatment times. Treatment can be as short as eight weeks.
20 lut 2018 · Guide for HCV treatment. The experience to date with these drugs demonstrated few contraindications to treating patients infected with HCV. Understanding the classes of drugs and treatment regimens available and expected results can facilitate high rates of response to treatment.
23 sie 2023 · HCV guidance: Recommendations for testing, managing, and treating hepatitis C. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. https://www.hcvguidelines.org/.
24 maj 2014 · The treatment of chronic hepatitis C virus (HCV) is evolving rapidly. In 2014, the standard of care and new backbone of HCV treatment is the polymerase inhibitor sofosbuvir (SOF). Our treatment approach in patients with HCV genotype 1 is 12 weeks of SOF, peginterferon (PEGINF), and ribavirin (RBV).
Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a ...
In contrast, a positive anti-HCV test result by enzyme immunosorbent assay is adequate for confirming infection in a high-risk patient who has evidence of chronic hepatitis. 1 If anti-HCV antibody is confirmed by RIBA in a low-risk patient, a physician should seek evidence of liver disease by physical examination and determination of the serum ALT.
Hepatitis C: Testing Algorithm for Screening and Diagnosis. Clear serum specimen. Screening of all persons aged 18 to 79 years*. Diagnostic testing: Patient with abnormal liver enzymes with or without symptoms.
